Jump to main content
Jump to site search

Issue 19, 2017, Issue in Progress
Previous Article Next Article

Graphene quantum dot-based theranostic agents for active targeting of breast cancer

Author affiliations

Abstract

A novel graphene quantum dot (GQD)-based nanocarrier labeled with Herceptin (HER) and β-cyclodextrin (β-CD) was developed as a promising theranostic candidate for the treatment of breast cancer. Each component of this nanocarrier plays a critical role in providing multiple functions to achieve enhanced anticancer activities. HER provides active targeting to HER2-overexpressed breast cancer to enhance accumulation in the cancer cells. β-CD provides a site for loading of a hydrophobic anticancer drug, doxorubicin (DOX), via “host–guest” chemistry. The nanocarriers also provide diagnostic effects due to the blue-color emission of the GQDs. In response to the acidic environment of cancer cells, the GQD-complex degraded rapidly and the DOX was released in a controlled manner to inhibit proliferation of cancer cells. This multi-functional drug delivery system leads to a synergistically enhanced anticancer strategy which provides treatment and diagnosis. The intracellular trafficking results, along with cell viability and confocal laser scanning microscopy, suggest that the GQD-complex offers a viable strategy for HER2-overexpressed breast cancer-targeting drug delivery applications.

Graphical abstract: Graphene quantum dot-based theranostic agents for active targeting of breast cancer

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Oct 2016, accepted on 17 Jan 2017 and first published on 14 Feb 2017


Article type: Paper
DOI: 10.1039/C6RA25949A
Citation: RSC Adv., 2017,7, 11420-11427
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Graphene quantum dot-based theranostic agents for active targeting of breast cancer

    N. R. Ko, M. Nafiujjaman, J. S. Lee, H.-N. Lim, Y.-k. Lee and I. K. Kwon, RSC Adv., 2017, 7, 11420
    DOI: 10.1039/C6RA25949A

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements